CU20060116A7 - DERIVATIVES OF 3-CYCALALKYLAMINOPIRROLIDINE AS CHEMIOKIN RECEPTORS MODULATORS - Google Patents

DERIVATIVES OF 3-CYCALALKYLAMINOPIRROLIDINE AS CHEMIOKIN RECEPTORS MODULATORS

Info

Publication number
CU20060116A7
CU20060116A7 CU20060116A CU20060116A CU20060116A7 CU 20060116 A7 CU20060116 A7 CU 20060116A7 CU 20060116 A CU20060116 A CU 20060116A CU 20060116 A CU20060116 A CU 20060116A CU 20060116 A7 CU20060116 A7 CU 20060116A7
Authority
CU
Cuba
Prior art keywords
derivatives
chemokine
ccr2
ccr5
modulators
Prior art date
Application number
CU20060116A
Other languages
Spanish (es)
Other versions
CU23667B7 (en
Inventor
Chagsheng Zheng
Yingxin Zhang
Chu-Biao Xue
Anlai Wang
Darius J Robinson
Brian Metcalf
Amy Qi Han
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Priority to CU20060116A priority Critical patent/CU23667B7/en
Publication of CU20060116A7 publication Critical patent/CU20060116A7/en
Publication of CU23667B7 publication Critical patent/CU23667B7/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con derivados de 3-cicloalquilaminopirrolidona de la fórmula I: (donde R1, R2, R3, R4, R5, R6, R7, X, Y y Z son como se define aquí) los cuales son usados como moduladores de la actividad del receptor de quimiocina. En particular estos compuestos son útiles como moduladores de receptores de quimiocina y más específicamente como moduladores de receptor CCR2 y/o CCR5: Los compuestos y las composiciones de la invención pueden unirse a los receptores de quimiocina, ej. los receptores de quimiocina CCR2 y/o CCR5, y son usados para tratar enfermedades asociadas con quimiocina, ej. CCR2 y/o CCR5 actividad, tales como ateroesclerosis, restinosis, lupus, rechazo de transplante de órganos y artritis reumatoidea. ESPACIO PARA FÓRMULAThe present invention relates to 3-cycloalkylaminopyrrolidone derivatives of the formula I: (where R1, R2, R3, R4, R5, R6, R7, X, Y and Z are as defined herein) which are used as modulators of chemokine receptor activity. In particular, these compounds are useful as chemokine receptor modulators and more specifically as CCR2 and / or CCR5 receptor modulators: The compounds and compositions of the invention can bind to chemokine receptors, e.g. chemokine receptors CCR2 and / or CCR5, and are used to treat diseases associated with chemokine, e.g. CCR2 and / or CCR5 activity, such as atherosclerosis, restinosis, lupus, organ transplant rejection and rheumatoid arthritis. FORMULA SPACE

CU20060116A 2006-06-07 2006-06-07 DERIVATIVES OF 3-CYCALALKYLAMINOPIRROLIDINE AS CHEMIOKIN RECEPTORS MODULATORS CU23667B7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20060116A CU23667B7 (en) 2006-06-07 2006-06-07 DERIVATIVES OF 3-CYCALALKYLAMINOPIRROLIDINE AS CHEMIOKIN RECEPTORS MODULATORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20060116A CU23667B7 (en) 2006-06-07 2006-06-07 DERIVATIVES OF 3-CYCALALKYLAMINOPIRROLIDINE AS CHEMIOKIN RECEPTORS MODULATORS

Publications (2)

Publication Number Publication Date
CU20060116A7 true CU20060116A7 (en) 2010-07-20
CU23667B7 CU23667B7 (en) 2011-05-27

Family

ID=44280798

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20060116A CU23667B7 (en) 2006-06-07 2006-06-07 DERIVATIVES OF 3-CYCALALKYLAMINOPIRROLIDINE AS CHEMIOKIN RECEPTORS MODULATORS

Country Status (1)

Country Link
CU (1) CU23667B7 (en)

Also Published As

Publication number Publication date
CU23667B7 (en) 2011-05-27

Similar Documents

Publication Publication Date Title
CR8455A (en) DERIVATIVES OF 3- CYCLOALKYLAMINOPIRROLIDINE AS CHEMIOKIN RECEPTORS MODULATORS
ECSP055856A (en) 3-AMINOPIRROLIDINE DERIVATIVES AS CHEMOCINE RECEPTORS MODULATORS
GT200400173A (en) ARIL OR HETEROARIL AMIDA COMPOUNDS
EA201290296A1 (en) CYCLIC PEPTIDES SPECIFIC TO THE MELANOCORTIN-1 RECEPTOR
CR10060A (en) 3-AMINOCICLOPENTANOCARBOXAMIDS AS CHEMIOKIN RECEPTORS MODULATORS
MA32536B1 (en) ORGANIC COMPOUNDS
ECSP099660A (en) 3-IMIDAZOLIL-INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
PE20080274A1 (en) DERIVATIVES OF DIOXO-ALKANES AND DIOXO-ALKENES REPLACED AS MODULATORS OF THE VANILLOID RECEPTOR SUBTYPE 1 (TRPV1)
PE20151144A1 (en) RETINOID RELATED GAMMA RECEPTOR ORPHAN MODULATORS (ROR - GAMMA) FOR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
UY32140A (en) AZAINDAZOL COMPOUNDS AS AN RECRUITOR OF THE RECEIVER OF CCR1
ECSP067121A (en) 3-AMINOCICLOPENTANOCARBOXAMIDS AS CHEMIOKIN RECEPTORS MODULATORS
UY32098A (en) HETEROARILOS SUBSTITUTED
ATE500250T1 (en) AZETIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
ECSP109844A (en) SPIROCICLES AS INHIBITORS OF THE 11-BETA HYDROXIESTEROID DEHYDROGENASE TYPE 1
ECSP099572A (en) ANTI-CXCL13 MONOCLONAL ANTIBODIES
BR112014030474A2 (en) new bicyclic thiophenylamide compounds
GT200600224A (en) METHODS TO PURIFY TIGECICLINE
EA200602242A1 (en) 3-AMINOCYCLOPENTANCARBOXAMIDES AS CHEMOKINE RECEPTOR MODULATORS
EA200601895A1 (en) 3- (4-HETEROAARYLCYCLOGEXYLAMINO) CYCLOPENTANKARBOXAMIDES AS CHEMOKIN RECEPTOR MODULATORS
GT200600222A (en) TIGECICLINE AND METHODS TO PREPARE 9-AMINOMINOCICLILNA
CO6470792A2 (en) ARILSULFONAMIDE 2.5-DISPOSED CCR3 ANTAGONISTS
EA200970662A1 (en) TRICYCLIC COMPOUNDS AND THEIR APPLICATION AS GLUCOCORTICOID RECEPTOR MODULATORS
PE20121109A1 (en) PROPHARMACES OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF THE ACTIVITY OF THE CHEMOKINE RECEPTOR
GT200600422A (en) CARBOXAMIDE DERIVATIVES AS ANTAGONISTS OF THE MUSCARINIC RECEIVER
CL2011002619A1 (en) Compounds derived from arylsulfonamides, modulators of ccr3 receptor activity; pharmaceutical composition comprising them; Useful in the treatment of an inflammatory disease such as asthma, allergic rhinitis, atopic dermatitis, epoc among others.

Legal Events

Date Code Title Description
FG Grant of patent